New cloud-based platform is being developed to integrate artificial intelligence, automated quality control and healthcare data connectivity to support next-generation precision medicine workflows.

Beijing, China, July 15, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (NASDAQ:ITOC) (the "Company"), a technology-driven healthcare company focused on developing innovative digital medical solutions, today announced continued progress in the development of its next-generation AI-enabled Treatment Planning System ("TPS") Cloud Platform through Mili (Jiangsu) Medical Technology Co., Ltd. ("Mili Medical"), a technology company focused on digital solutions for nuclear medicine and radiation treatment planning. The Company, through its indirect PRC subsidiary, has held a 60% equity interest in Mili Medical since its establishment.